Assembly Bill A5285

2025-2026 Legislative Session

Relates to prescription labels for mifepristone and misoprostol

download bill text pdf

Sponsored By

Current Bill Status - In Assembly Committee

  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

2025-A5285 (ACTIVE) - Details

See Senate Version of this Bill:
S4587
Current Committee:
Assembly Rules
Law Section:
Education Law
Laws Affected:
Amd §§6807 & 6810, Ed L (as proposed in S.36-A and A.2145-A); add §280-d, Pub Health L

2025-A5285 (ACTIVE) - Summary

Provides the prescription label for mifepristone or misoprostol may include the address of the dispensing health care practice and shall include the address of the prescribing health care practice at the prescriber's request; provides that a health care prescriber shall inform a patient if such prescriber has included or has requested to include the name or address of the prescribing health care practice instead of the name of such prescriber on the prescription label when prescribing mifepristone or misoprostol.

2025-A5285 (ACTIVE) - Bill Text download pdf 

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   5285
 
                        2025-2026 Regular Sessions
 
                           I N  A S S E M B L Y
 
                             February 12, 2025
                                ___________
 
 Introduced  by M. of A. REYES -- read once and referred to the Committee
   on Higher Education
 
 AN ACT to amend the education law and the public health law, in relation
   to prescription labels for mifepristone and misoprostol
 
   THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
 BLY, DO ENACT AS FOLLOWS:

   Section  1.  Paragraph  b-1  of  subdivision  1 of section 6807 of the
 education law, as added by a chapter of the laws of  2025  amending  the
 education law relating to the labeling of mifepristone, misoprostol, and
 their  generic alternatives, as proposed in legislative bills numbers S.
 36-A and A. 2145-A, is amended to read as follows:
   b-1. Notwithstanding paragraph b of  this  section,  the  prescription
 label  for  mifepristone[,]  OR misoprostol[, and their generic alterna-
 tives] may include the name OR ADDRESS of  the  dispensing  health  care
 practice instead of the name of the dispenser.
   § 2. Subdivision 1-a of section 6810 of the education law, as added by
 a chapter of the laws of 2025 amending the education law relating to the
 labeling  of  mifepristone, misoprostol, and their generic alternatives,
 as proposed in legislative bills numbers  S.  36-A  and  A.  2145-A,  is
 amended to read as follows:
   1-a.   Notwithstanding   subdivision  one  of  this  section,  at  the
 prescriber's request, the  prescription  label  for  mifepristone[,]  OR
 misoprostol[, and their generic alternatives may] SHALL include the name
 OR  ADDRESS  of the prescribing health care practice instead of the name
 of the prescriber.
   § 3. The public health law is amended by adding a new section 280-d to
 read as follows:
   § 280-D. PATIENT NOTIFICATION OF PRESCRIPTION LABEL CHANGE.  A  HEALTH
 CARE PRESCRIBER SHALL INFORM THE PATIENT IF SUCH PRESCRIBER HAS INCLUDED
 OR  HAS  REQUESTED  TO  INCLUDE  THE  NAME OR ADDRESS OF THE PRESCRIBING

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD09082-01-5
 A. 5285                             2

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.